Prazosin Hydrochloride Structural Formula (31f2c71e 2c0d 4989 9bdb 13d490e0d155 01)
Prazosin Hydrochloride Capsule
Product Images NDC 70518-1443
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Prazosin Hydrochloride (NDC 70518-1443). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Prazosin HCl 5mg 70518 1443 02
This is a medication with the active ingredient Prazosin HCI, available in a capsule form of 5mg. The NDC number is 70518-1442-02 and the manufacturing company is Mylan located in Morgantown, Wyoming. There is an instructions insert inside the packaging, and it should be kept between 20-25°C (B-77°F) with permitted excursions of 15-30°C (59-26°F) [See USP]. The medication was repackaged by RemedyRepack Inc. in Indiana, PA 15701. There is no expiry date nor a Lot number available. The medication is strictly for Rx only and should be kept out of reach from children.*
Prazosin HCl 5mg 70518 1443 03
Prazosin HCI is a capsule with a strength of 5 mg, and it is only available with a prescription. The medicine is manufactured by Mylan located in Morgantown, WY 26505, and repackaged by RemedRepack in Indiana, PA 15701. It has an NDC number of 70518-1442-02, and the package insert should be followed. The medication should be kept out of reach from children and stored at 20-25°C (88-77°F), with excursions permitted o 15-30°C (59-86°F). The LOT number is not available from the supplied text.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
